Current Stem Cell Research and Therapy
Journal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | 2.1 | Q4 | 21.9% | 0.538 | Q2 | 63.7% |
| 2024 | 2.2 | Q4 | 23.0% | 0.529 | Q3 | 64.1% |
| 2023 | 2.1 | Q4 | 19.6% | 0.525 | Q2 | 66.5% |
| 2022 | 2.7 | Q4 | 23.4% | 0.552 | Q2 | 69.5% |
| 2021 | 3.8 | Q3 | 35.2% | 0.572 | Q2 | 71.4% |
| 2020 | — | — | 0.802 | Q2 | 79.8% | |
| 2019 | — | — | 0.577 | Q2 | 71.5% | |
| 2018 | — | — | 0.595 | Q2 | 70.5% | |
Impact history
Annual SJR and Impact Factor trend.
SJRIF
Journal record
eISSN
2212-3946
ISSN
1574-888X
country
AEcoverage
2006-2026